Multifunctional magnetoliposomes as drug delivery vehicles for the potential treatment of Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease. Therefore, development of novel technologies and strategies to treat PD is a global health priority. Current treatments include administration of Levodopa, monoamine oxidase inhibitors, catechol-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cifuentes, Javier, Cifuentes-Almanza, Santiago, Ruiz Puentes, Paola, Quezada, Valentina, González Barrios, Andrés Fernando, Calderón-Peláez, María-Angélica, Velandia-Romero, Myriam Lucia, Rafat, Marjan, Muñoz-Camargo, Carolina, Albarracín, Sonia L., Cruz, Juan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196638/
https://www.ncbi.nlm.nih.gov/pubmed/37214285
http://dx.doi.org/10.3389/fbioe.2023.1181842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196638/
https://www.ncbi.nlm.nih.gov/pubmed/37214285
http://dx.doi.org/10.3389/fbioe.2023.1181842

Ejemplares similares